Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)
Michele M. Corsini(Mayo Clinic in Arizona), Leonard L. Gunderson(Mayo Clinic in Arizona), Aminah Jatoi(Mayo Clinic in Arizona), David M. Nagorney(Mayo Clinic in Arizona), S. Bhatia(Mayo Clinic in Arizona), Michael G. Haddock(Mayo Clinic in Arizona), George P. Kim(Mayo Clinic in Arizona), Robert C. Miller(Mayo Clinic), Michael B. Farnell(Hudson Institute), Robert R. McWilliams(Mayo Clinic in Arizona), John H. Donohue(Columbus Community Clinical Oncology Program), Matthew J. Iott(Mayo Clinic in Arizona)
Cited by 270
Related Papers
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
|Nature Genetics|2009|724
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33
|Nature Genetics|2010|614
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
|JAMA|2018|580
Risk Factors for Mortality After Surgery in Patients With Cirrhosis
|Gastroenterology|2007|571